BioNexus Gene Lab (BGLC) Free Cash Flow (2018 - 2026)
BioNexus Gene Lab recorded quarterly Free Cash Flow of -$147996.0 in Q1 2026, down 115.41% quarter-over-quarter from $960085.0 in Q4 2025, and up 82.24% year-over-year from -$81211.2 in Q1 2025.
BioNexus Gene Lab's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$147996.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 82.24% year-over-year to -$147996.0; the TTM figure through Mar 2026 stood at -$1.2 million (up 61.53% YoY), while the FY2025 annual figure was -$1.9 million, up 19.17% from the prior year.
- Free Cash Flow came in at -$147996.0 for Q1 2026 at BioNexus Gene Lab, down from $960085.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $960085.0 in Q4 2025 to a low of -$1.8 million in Q3 2024.
- A 5-year average of -$339022.7 and a median of -$147996.0 in 2026 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 346.18% in 2025 and fell as far as 1309.73% in 2025.
- BioNexus Gene Lab's Free Cash Flow stood at $476739.0 in 2022, then slumped by 264.34% to -$783463.0 in 2023, then soared by 127.47% to $215181.0 in 2024, then jumped by 346.18% to $960085.0 in 2025, then sank by 115.41% to -$147996.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$147996.0, $960085.0, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 898.00 Mn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 800,000.00 |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 758.00 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 1.10 Bn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | -19.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | -538.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 247.57 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 130.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -147,996.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147,996.00 |
| Mar 31, 2026 | -147,996.00 |
| Dec 31, 2025 | 960,085.00 |
| Dec 31, 2025 | 960,085.00 |
| Sep 30, 2025 | -1.24 Mn |
| Sep 30, 2025 | -1.24 Mn |
| Jun 30, 2025 | -759,366.00 |
| Jun 30, 2025 | -759,366.00 |
| Mar 31, 2025 | -833,124.00 |
| Mar 31, 2025 | -833,124.00 |
| Dec 31, 2024 | 215,181.00 |
| Dec 31, 2024 | 215,181.00 |
| Sep 30, 2024 | -1.80 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | -674,108.00 |
| Jun 30, 2024 | -674,108.00 |
| Mar 31, 2024 | -59,098.00 |
| Mar 31, 2024 | -59,098.00 |
| Dec 31, 2023 | -783,463.00 |
| Dec 31, 2023 | -783,463.00 |
| Sep 30, 2023 | -1.01 Mn |
| Sep 30, 2023 | -1.01 Mn |
| Jun 30, 2023 | -65,308.00 |
| Jun 30, 2023 | -65,308.00 |
| Mar 31, 2023 | -116,620.00 |
| Mar 31, 2023 | -116,620.00 |
| Dec 31, 2022 | 459,712.00 |
| Dec 31, 2022 | 459,712.00 |
| Sep 30, 2022 | 271,747.00 |
| Sep 30, 2022 | 271,747.00 |
| Jun 30, 2022 | -163,778.00 |
| Jun 30, 2022 | -163,778.00 |
| Mar 31, 2022 | -70,030.00 |
| Mar 31, 2022 | -70,030.00 |
| Dec 31, 2021 | 481,728.00 |
| Dec 31, 2021 | 481,728.00 |
| Sep 30, 2021 | 315,459.00 |
| Sep 30, 2021 | 315,459.00 |
| Jun 30, 2021 | -905,809.00 |
| Jun 30, 2021 | -905,809.00 |
| Mar 31, 2021 | 114,621.00 |
| Mar 31, 2021 | 114,621.00 |
| Dec 31, 2020 | 511,166.00 |
| Dec 31, 2020 | 511,166.00 |
| Sep 30, 2020 | 754,744.00 |
| Sep 30, 2020 | 754,744.00 |
| Jun 30, 2020 | -157,196.00 |
| Jun 30, 2020 | -157,196.00 |
| Mar 31, 2020 | -977,655.00 |
| Mar 31, 2020 | -977,655.00 |
| Dec 31, 2019 | -65,507.00 |
| Dec 31, 2019 | -65,507.00 |
| Sep 30, 2019 | -53,883.00 |
| Sep 30, 2019 | -53,883.00 |
| Jun 30, 2019 | -76,770.00 |
| Jun 30, 2019 | -76,770.00 |
| Mar 31, 2019 | -33,930.00 |
| Mar 31, 2019 | -33,930.00 |
| Dec 31, 2018 | 261,079.00 |
| Dec 31, 2018 | 261,079.00 |
| Mar 31, 2018 | -656,371.00 |
| Mar 31, 2018 | -656,371.00 |